Immune Therapeutics Inc (OTCQB:IMUN)

During the Trading Day
0.0311 +0.00058 / +1.90%
As of 3:53pm ET
Day’s Change
During After-Hours   Switch to standard view »
0.0313 +0.00023 / +0.74%
Volume: --

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues0.000.0016.2K3.5K
Depreciation And Amortization2.9M2.9M594.8K1.6K
Operating ExpensesGross Income-2.9M-2.9M----
General Expenses93.1M30.7M10.0M9.5M
Other Operating Expenses0.000.0046.2K0.00
Research And Development22.0M7.5M977.2K444.2K
Total Operating Expenses96.0M33.6M10.6M9.5M
Non-Operating ExpensesOperating Income-96.0M-33.6M-10.6M-9.5M
Extraordinary Charge-8.6M-15.9M-6.1M-6.8M
Interest Expense On Debt1.4M388.2K271.0K3.4M
Other Expenses-224.00-783.000.000.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-106.1M-49.9M-16.9M-19.8M
Minority Interest0.00-1.7M-635.7K-297.6K
Net Income-106.1M-48.3M-16.3M-19.5M
Shares To Calculate EPSShares To Calculate EPS57.2M98.5M153.2M216.7M
Shares To Calculate EPS Diluted57.2M98.5M153.2M216.7M
Earnings Per ShareEPS-$1.85-$0.49-$0.11-$0.09
EPS Diluted-$1.85-$0.49-$0.11-$0.09